List of Figures:
Figure 1. Research Method Flow Chart 15
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 18
Figure 3. Global Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031 20
Figure 4. Global Bioanalytical Testing Services Market, 2021-2031, $ mn 23
Figure 5. Impact of COVID-19 on Business 26
Figure 6. Leading Causes of Death in the World, 2019-2020, million 28
Figure 7. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million 29
Figure 8. World Population 65 and Over, % of Total Population, 1950-2060 29
Figure 9. Primary Drivers and Impact Factors of Global Bioanalytical Testing Services Market 31
Figure 10. Primary Restraints and Impact Factors of Global Bioanalytical Testing Services Market 34
Figure 11. Investment Opportunity Analysis 38
Figure 12. Porter’s Fiver Forces Analysis of Global Bioanalytical Testing Services Market 41
Figure 13. Breakdown of Global Bioanalytical Testing Services Market by Molecule Type, 2021-2031, % of Revenue 46
Figure 14. Global Addressable Market Cap in 2022-2031 by Molecule Type, Value ($ mn) and Share (%) 46
Figure 15. Global Bioanalytical Testing Services Market by Molecule Type: Small Molecules, 2021-2031, $ mn 47
Figure 16. Global Bioanalytical Testing Services Market by Molecule Type: Large Molecules, 2021-2031, $ mn 48
Figure 17. Global Bioanalytical Testing Services Market by Large Molecules: LC-MS Studies, 2021-2031, $ mn 49
Figure 18. Global Bioanalytical Testing Services Market by Large Molecules: Immunoassays, 2021-2031, $ mn 50
Figure 19. Global Bioanalytical Testing Services Market by Large Molecules: Other Large Molecule Tests, 2021-2031, $ mn 51
Figure 20. Breakdown of Global Bioanalytical Testing Services Market by Application, 2021-2031, % of Sales Revenue 53
Figure 21. Global Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%) 53
Figure 22. Global Bioanalytical Testing Services Market by Application: Bioavailability and Bioequivalence Studies, 2021-2031, $ mn 54
Figure 23. Global Bioanalytical Testing Services Market by Application: Pharmacokinetics (PK), 2021-2031, $ mn 55
Figure 24. Global Bioanalytical Testing Services Market by Application: Pharmacodynamics (PD), 2021-2031, $ mn 56
Figure 25. Global Bioanalytical Testing Services Market by Application: Absorption, Distribution, Metabolism, Excretion (ADME), 2021-2031, $ mn 57
Figure 26. Global Bioanalytical Testing Services Market by Application: Other Applications, 2021-2031, $ mn 58
Figure 27. Breakdown of Global Bioanalytical Testing Services Market by Test Type, 2021-2031, % of Sales Revenue 60
Figure 28. Global Addressable Market Cap in 2022-2031 by Test Type, Value ($ mn) and Share (%) 60
Figure 29. Global Bioanalytical Testing Services Market by Test Type: Cell-based Assays, 2021-2031, $ mn 61
Figure 30. Global Bioanalytical Testing Services Market by Cell-based Assays: Bacterial Cell-based Assays, 2021-2031, $ mn 62
Figure 31. Global Bioanalytical Testing Services Market by Cell-based Assays: Viral Cell-based Assays, 2021-2031, $ mn 63
Figure 32. Global Bioanalytical Testing Services Market by Test Type: Virology Testing, 2021-2031, $ mn 64
Figure 33. Global Bioanalytical Testing Services Market by Virology Testing: In Vitro Virology Testing, 2021-2031, $ mn 65
Figure 34. Global Bioanalytical Testing Services Market by Virology Testing: In Vivo Virology Testing, 2021-2031, $ mn 66
Figure 35. Global Bioanalytical Testing Services Market by Virology Testing: Species-Specific Viral PCR Assays, 2021-2031, $ mn 67
Figure 36. Global Bioanalytical Testing Services Market by Test Type: Serology, Immunogenicity, and Neutralizing Antibodies (SINA), 2021-2031, $ mn 68
Figure 37. Global Bioanalytical Testing Services Market by Serology, Immunogenicity, and Neutralizing Antibodies (SINA): Bacterial Serology, Immunogenicity, and Neutralizing Antibodies, 2021-2031, $ mn 69
Figure 38. Global Bioanalytical Testing Services Market by Serology, Immunogenicity, and Neutralizing Antibodies (SINA): Viral Serology, Immunogenicity, and Neutralizing Antibodies, 2021-2031, $ mn 70
Figure 39. Global Bioanalytical Testing Services Market by Test Type: Method Development Optimization and Validation (MDOV), 2021-2031, $ mn 71
Figure 40. Global Bioanalytical Testing Services Market by Test Type: Biomarker Testing, 2021-2031, $ mn 72
Figure 41. Global Bioanalytical Testing Services Market by Test Type: Pharmacokinetic Testing, 2021-2031, $ mn 73
Figure 42. Global Bioanalytical Testing Services Market by Test Type: Other Test Types, 2021-2031, $ mn 74
Figure 43. Breakdown of Global Bioanalytical Testing Services Market by Workflow Process, 2021-2031, % of Revenue 76
Figure 44. Global Addressable Market Cap in 2022-2031 by Workflow Process, Value ($ mn) and Share (%) 76
Figure 45. Global Bioanalytical Testing Services Market by Workflow Process: Sample Preparation, 2021-2031, $ mn 77
Figure 46. Global Bioanalytical Testing Services Market by Sample Preparation: Protein Precipitation, 2021-2031, $ mn 78
Figure 47. Global Bioanalytical Testing Services Market by Sample Preparation: Liquid-liquid Extraction (LLE), 2021-2031, $ mn 79
Figure 48. Global Bioanalytical Testing Services Market by Sample Preparation: Solid Phase Extraction (SPE), 2021-2031, $ mn 80
Figure 49. Global Bioanalytical Testing Services Market by Workflow Process: Sample Analysis, 2021-2031, $ mn 81
Figure 50. Global Bioanalytical Testing Services Market by Sample Analysis: Hyphenated Technique, 2021-2031, $ mn 83
Figure 51. Global Bioanalytical Testing Services Market by Sample Analysis: Chromatographic Technique, 2021-2031, $ mn 84
Figure 52. Global Bioanalytical Testing Services Market by Sample Analysis: Electrophoresis, 2021-2031, $ mn 85
Figure 53. Global Bioanalytical Testing Services Market by Sample Analysis: Ligand Binding Assay, 2021-2031, $ mn 86
Figure 54. Global Bioanalytical Testing Services Market by Sample Analysis: Mass Spectrometry, 2021-2031, $ mn 87
Figure 55. Global Bioanalytical Testing Services Market by Sample Analysis: Nuclear Magnetic Resonance, 2021-2031, $ mn 88
Figure 56. Global Bioanalytical Testing Services Market by Workflow Process: Other Workflow Processes, 2021-2031, $ mn 89
Figure 57. Breakdown of Global Bioanalytical Testing Services Market by Therapeutic Area, 2021-2031, % of Revenue 91
Figure 58. Global Addressable Market Cap in 2022-2031 by Therapeutic Area, Value ($ mn) and Share (%) 91
Figure 59. Global Bioanalytical Testing Services Market by Therapeutic Area: Oncology, 2021-2031, $ mn 92
Figure 60. Global Bioanalytical Testing Services Market by Therapeutic Area: Neurology, 2021-2031, $ mn 93
Figure 61. Global Bioanalytical Testing Services Market by Therapeutic Area: Infectious Diseases, 2021-2031, $ mn 94
Figure 62. Global Bioanalytical Testing Services Market by Therapeutic Area: Gastroenterology, 2021-2031, $ mn 95
Figure 63. Global Bioanalytical Testing Services Market by Therapeutic Area: Cardiology, 2021-2031, $ mn 96
Figure 64. Global Bioanalytical Testing Services Market by Therapeutic Area: Other Therapeutic Areas, 2021-2031, $ mn 97
Figure 65. Breakdown of Global Bioanalytical Testing Services Market by End User, 2021-2031, % of Revenue 98
Figure 66. Global Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%) 99
Figure 67. Global Bioanalytical Testing Services Market by End User: Pharma and Biopharma Companies, 2021-2031, $ mn 100
Figure 68. Global Bioanalytical Testing Services Market by End User: Contract Development and Manufacturing Organizations (CDMOs), 2021-2031, $ mn 101
Figure 69. Global Bioanalytical Testing Services Market by End User: Contract Research Organizations (CROs), 2021-2031, $ mn 102
Figure 70. Global Market Snapshot by Region 103
Figure 71. Geographic Spread of Worldwide Bioanalytical Testing Services Market, 2021-2031, % of Sales Revenue 104
Figure 72. Global Addressable Market Cap in 2022-2031 by Region, Value ($ mn) and Share (%) 105
Figure 73. North American Bioanalytical Testing Services Market, 2021-2031, $ mn 108
Figure 74. Breakdown of North America Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue 109
Figure 75. Contribution to North America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 110
Figure 76. U.S. Bioanalytical Testing Services Market, 2021-2031, $ mn 112
Figure 77. Canada Bioanalytical Testing Services Market, 2021-2031, $ mn 114
Figure 78. Bioanalytical Testing Services Market in Mexico, 2021-2031, $ mn 116
Figure 79. European Bioanalytical Testing Services Market, 2021-2031, $ mn 119
Figure 80. Breakdown of European Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue 120
Figure 81. Contribution to Europe 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 121
Figure 82. Bioanalytical Testing Services Market in Germany, 2021-2031, $ mn 122
Figure 83. Bioanalytical Testing Services Market in U.K., 2021-2031, $ mn 124
Figure 84. Bioanalytical Testing Services Market in France, 2021-2031, $ mn 126
Figure 85. Bioanalytical Testing Services Market in Spain, 2021-2031, $ mn 128
Figure 86. Bioanalytical Testing Services Market in Italy, 2021-2031, $ mn 130
Figure 87. Bioanalytical Testing Services Market in Russia, 2021-2031, $ mn 132
Figure 88. Bioanalytical Testing Services Market in Rest of Europe, 2021-2031, $ mn 134
Figure 89. Asia-Pacific Bioanalytical Testing Services Market, 2021-2031, $ mn 137
Figure 90. Breakdown of APAC Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue 137
Figure 91. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 139
Figure 92. Bioanalytical Testing Services Market in Japan, 2021-2031, $ mn 141
Figure 93. Bioanalytical Testing Services Market in China, 2021-2031, $ mn 143
Figure 94. Bioanalytical Testing Services Market in Australia, 2021-2031, $ mn 145
Figure 95. Bioanalytical Testing Services Market in India, 2021-2031, $ mn 147
Figure 96. Bioanalytical Testing Services Market in South Korea, 2021-2031, $ mn 149
Figure 97. Bioanalytical Testing Services Market in Rest of APAC, 2021-2031, $ mn 151
Figure 98. South America Bioanalytical Testing Services Market, 2021-2031, $ mn 154
Figure 99. Breakdown of South America Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue 154
Figure 100. Contribution to South America 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 155
Figure 101. Bioanalytical Testing Services Market in Argentina, 2021-2031, $ mn 156
Figure 102. Bioanalytical Testing Services Market in Brazil, 2021-2031, $ mn 158
Figure 103. Bioanalytical Testing Services Market in Chile, 2021-2031, $ mn 160
Figure 104. Bioanalytical Testing Services Market in Rest of South America, 2021-2031, $ mn 162
Figure 105. Bioanalytical Testing Services Market in Middle East and Africa (MEA), 2021-2031, $ mn 164
Figure 106. Breakdown of MEA Bioanalytical Testing Services Market by Country, 2021 and 2031, % of Revenue 164
Figure 107. Contribution to MEA 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%) 165
Figure 108. Bioanalytical Testing Services Market in UAE, 2021-2031, $ mn 166
Figure 109. Bioanalytical Testing Services Market in Saudi Arabia, 2021-2031, $ mn 168
Figure 110. Bioanalytical Testing Services Market in South Africa, 2021-2031, $ mn 170
Figure 111. Growth Stage of Global Bioanalytical Testing Services Industry over the Forecast Period 173
Global bioanalytical testing services market will reach $7,902.9 million by 2031, growing by 9.1% annually over 2021-2031, driven by the rising demand for analytical testing of biologics and biosimilars amid COVID-19 pandemic, increasing preference for outsourcing analytical testing, growing R&D expenditure in the pharmaceutical and biopharmaceutical industries, and the rising adoption of the Quality by Design (QbD) approach. Highlighted with 88 tables and 111 figures, this 193-page report “Global Bioanalytical Testing Services Market 2021-2031 by Molecule Type (Small, Large), Application (Bioavailability and Bioequivalence, PK, PD, ADME), Test Type (Cell-based, Virology, SINA, MDOV, Biomarker), Workflow Process (Sample Preparation, Sample Analysis, Others), Therapeutic Area (Oncology, Neurology, Infectious Diseases, Gastroenterology, Cardiology), End User (Pharma and Biopharma Companies, CDMOs, CROs), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global bioanalytical testing services market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.) In-depth qualitative analyses include identification and investigation of the following aspects: • Market Structure • Growth Drivers • Restraints and Challenges • Emerging Product Trends & Market Opportunities • Porter’s Fiver Forces The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global bioanalytical testing services market in every aspect of the classification from perspectives of Molecule Type, Application, Test Type, Workflow Process, Therapeutic Area, End User, and Region. Based on Molecule Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Small Molecules • Large Molecules o LC-MS Studies o Immunoassays o Other Large Molecule Tests Based Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Bioavailability and Bioequivalence Studies • Pharmacokinetics (PK) • Pharmacodynamics (PD) • Absorption, Distribution, Metabolism, Excretion (ADME) • Other Applications By Test Type, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Cell-based Assays o Bacterial Cell-based Assays o Viral Cell-based Assays • Virology Testing o In Vitro Virology Testing o In Vivo Virology Testing o Species-Specific Viral PCR Assays • Serology, Immunogenicity, and Neutralizing Antibodies (SINA) o Bacterial Serology, Immunogenicity, and Neutralizing Antibodies o Viral Serology, Immunogenicity, and Neutralizing Antibodies • Method Development Optimization and Validation (MDOV) • Biomarker Testing • Pharmacokinetic Testing • Other Test Types By Workflow Process, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Sample Preparation o Protein Precipitation o Liquid-liquid Extraction (LLE) • Sample Analysis o Hyphenated Technique o Chromatographic Technique o Electrophoresis o Ligand Binding Assay o Mass Spectrometry o Nuclear Magnetic Resonance • Other Workflow Processes By Therapeutic Area, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Oncology • Neurology • Infectious Diseases • Gastroenterology • Cardiology • Other Therapeutic Areas By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section. • Pharma and Biopharma Companies • Contract Development and Manufacturing Organizations (CDMOs) • Contract Research Organizations (CROs) Geographically, the following regions together with the listed national/local markets are fully investigated: • North America (U.S., Canada, and Mexico) • Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Netherlands, Switzerland, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland) • APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines) • South America (Brazil, Chile, Argentina, Rest of South America) • MEA (UAE, Saudi Arabia, South Africa, Other Nations) For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Application, Workflow Process, and Therapeutic Area over the forecast years are also included. The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players. Selected Key Players: Charles River Laboratories International Inc. Covance Inc. Eurofins Scientific ICON PLC Intertek Group PLC IQVIA Holdings, Inc. Laboratory Corporation of America Holdings Medpace Holdings, Inc. Pace Analytical Services LLC. Parexel International Corporation PPD Inc. SGS SA Syneos Health, LLC Toxikon Corporation WuXi Apptech Co., Ltd. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Read More